7 th Edition and v0205 SSFs Presentation developed by April Fritz RHIT CTR Reno Nevada aprilafritzorg Celebrities Who Had Lung Cancer The Crowded Thorax Larynx Thyroid Trachea Thymus ID: 774829
Download Presentation The PPT/PDF document " TNM Staging of Lung Cancer " is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
TNM Staging of Lung Cancer 7th Edition and v02.05 SSFs
Presentation developed by
April Fritz, RHIT, CTRReno, Nevadaapril@afritz.org
Slide2Celebrities Who Had Lung Cancer
Slide3The Crowded Thorax
Larynx
Thyroid
Trachea
Thymus
Pleura
Sternum (cut away)
Aorta
Intercostal
muscles
Ribs
Diaphragm
Heart
Lungs
Slide4Upper lobe
Middle lobe
Lower lobe
C34.1
C34.2
C34.1
Carina
C34.3
C34.3
Trachea
C33.9
Lung Anatomy
showing ICD-O-3 codes
Slide5Important Anatomical Landmarks
Graphics source: Mediclip, Williams and Wilkins.
Right Lung
Left Lung
Hilum
Lingula
Apex
Apex
Lower lobe
Upper lobe
Upper lobe
Middle lobe
Slide6Trachea
Mainstem bronchus
Lobar bronchus
Segmental bronchus
Bronchiole
Alveolar duct
Alveolus
Adapted from R S Snell: Clinical Anatomy for Medical Students, 5th ed. 1995.
Respiratory Tract
Slide7Alveoli
Source: http://www.webschoolsolutions.com/patts/systems/lungs.htm#anatomy
Slide8The Mediastinum
Image source: mywebpages.comcast.net/ wnor/thoraxlesson3.htm
Clavicle
Superior mediastinum
Inferior mediastinum
Anterior mediastinum Middle mediastinum Posterior mediastinum
Slide9Bronchioloalveolar Carcinoma – New Terminology
From IASLC 2011: terms BAC and mixed subtype adenocarcinoma no longer used.
≤ 3 cm, NO stromal, lymphatic, vascular or pleural invasion, no necrosis, no growth patterns other than lepidic
Adenocarcinoma in situ, either serous (8140/2) or mucinous (8253/2; rare)
≤ 3 cm, with ≤ 5 mm area of stromal invasion or growth pattern(s) other than lepidic
Minimally Invasive Adenocarcinoma (MIA): Non-mucinous 8250/2; Mucinous
8257/3
use 8253/3 until
2018
Source: 2015 WHO Classification of Tumors of the Lung
Slide10Bronchioloalveolar Carcinoma – New Terminology
> 3 cm OR with lymphatic, vascular or pleural invasion OR necrosis OR > 5 mm area of stromal invasion OR growth pattern(s) other than lepidic
Serous: invasive adenocarcinoma, lepidic predominant (8250/3)
Mucinous: invasive mucinous adenocarcinoma (8253/3)
Source: 2015 WHO Classification of Tumors of the Lung
Slide11Invasive Adenocarcinoma
Subtypes and variants
Lepidic (formerly most mixed subtype tumors with non-mucinous BAC) – 8250/3
Acinar – 8551/3
Papillary – 8260/3
Solid – 8230/3
Micropapillary added as a new histologic subtype – 8265/3
Invasive mucinous adenocarcinoma (formerly mucinous BAC) – 8253/3
Colloid – 8480/3
Fetal – 8333/3
Enteric adenocarcinoma – 8144/3
Slide12Summary of Lung T Classification
TX Positive cytology only
T1 ≤ 3 cm
T1a ≤ 2 cm
T1b > 2–
<3
cm
T2 Main bronchus 2 cm from carina, invades visceral pleura, partial atelectasis
T2a > 3 cm to 5 cm
T2b > 5 cm to 7 cm
T3 > 7 cm; parietal pleura, chest wall, diaphragm,
pericardium, mediastinal pleura, main bronchus
< 2 cm from carina, total atelectasis, separate nodule(s) in same lobe
T4 Mediastinum, heart, great vessels, carina, trachea, esophagus, vertebral body; separate tumor nodule(s) in a different ipsilateral lobe
Slide13T1 Lung Cancer
Tumor 3 cm or less in size, surrounded by lung or visceral pleura; no invasion more proximal than a lobar bronchus
T1a ≤ 2 cmT1b > 2 to 3 cm
Source: UICC TNM-interactive, Wiley-Liss, 1998
Slide14T2 Lung Cancer
Source: UICC
TNM-interactive, Wiley-Liss, 1998
Tumor > 3 to 7 cm in size
T2a > 3 to 5 cm
T2b > 5 to 7 cm
Any of following:
Invading visceral
pleura (PL1, PL2)
In main bronchus
≥
2 cm from carina
Associated with atelectasis or
obstructive pneumonitis extending to hilar region but not involving entire lung
Slide15Atelectasis/Obstructive Pneumonitis
Source: www.upstate.edu/radiology/ olla/lung_cancer.htm
T2
Obstructive Pneumonitis
Do not code bronchopneumonia
T3
Atelectasis of Right Lung
Source: Medi-clip: Grant’s Atlas Images I, Thorax and Abdomen. Williams and Wilkins, 1998.
Slide16T3 Lung Cancer
(1)
Any of the following:Tumor > 7 cmAny of following:In main bronchus < 2 cm from carina without involving carinaAtelectasis or obstructive pneumonitis of entire lungSeparate tumor nodule(s) in same lobecontinued
Source: UICC TNM-interactive, Wiley-Liss, 1998
Slide17T3 Lung Cancer (2)
Any of the following:Direct invasion ofA. Chest wallB. DiaphragmC. Mediastinal pleuraD. Parietal pericardium— Phrenic nerve
Superior sulcus
Clavicle
Trachea
Ribs
Pleura
Pleural space
Pericardium
Diaphragm
A
A
B
D
D
C
Slide18Pancoast Tumor
T3 Pancoast tumor (superior sulcus tumor)T4 Superior sulcus tumor with encasement of subclavian vessels or involvement of superior branches of brachial plexus above C8
Superior
sulcus
Clavicle
Trachea
C8
Image source: http://www.mayoclinic.org/
brachial-plexus/details.html
Slide19A
B
C
D
E
T4 Lung Cancer
(1)
Direct invasion of any
of the following:
Mediastinum
Heart
Trachea
Great vessels
Carina
Not shown:
Esophagus
(behind trachea)
Adjacent rib
Vertebral body
(posterior to lung)
continued
A
B
C
D
E
Slide20T3 vs T4
T3
Multiple tumors in same lobe
Source: UICC TNM-interactive, Wiley-Liss, 1998
T4
Multiple tumors in different lobe
Slide21Superior vena cava
Main pulmonary arteryR and L pulmonary artery trunks*R and L superior pulmonary veins*R and L inferior pulmonary veins*AortaInferior vena cava* intrapericardial segments
Great Vessels (T4)
Superior vena cava
Heart
Great vessels
Slide22Direct Extension per TNM Manual
TNM
Phrenic nerve invasion
T3
Discontinuous pleural foci
T4
Vocal cord paralysis
T4*
SVC obstruction
T4*
Tracheal/esophageal compression
T4*
* unless primary is peripheral, then code in N
Details coming
Slide23Summary of Lung N and M
N1 Ipsilateral peribronchial, ipsilateral hilar
N2 Ipsilateral mediastinal, subcarinal
N3 Contralateral mediastinal or hilar, scalene
or supraclavicular
M1 Distant metastasis
M1a Separate tumour nodule(s) in a contralateral
lobe;
pleural nodules or
malignant
pleural
or pericardial effusion
M1b Distant metastasis
Slide24N3
N2
N1
N3
N3
N2
Adapted from R S Snell: Clinical Anatomy for Medical Students, 5th ed. 1995.
Lung Cancer Lymph Nodes
Lymph Nodes
N1 Same side
Intrapulmonary
Peribronchial
Hilar
By direct extension
N2 Same side
Mediastinal
Subcarinal
N3 Contralateral
Mediastinal
Hilar
Any scalene
Any supraclavicular
Slide25Lymph Node Stations
Not the same as N categories
Stations are based on surgical landmarks
Source: UICC
TNM-interactive
, Wiley-Liss, 1998
Slide26Lymph Nodes – N1 and N2
Ipsilateral bronchial
Hilar
Peribronchial
Image source: AJCC Cancer Staging Atlas, Springer-Verlag, 2006.
Hilar Adenopathy
Image source: www.uveitis.org/images/sarcoid7.jpg
Slide27Lymph Nodes – N2
Image source: AJCC Cancer Staging Atlas, Springer-Verlag, 2006.
Subcarinal
Ipsilateral mediastinal
Source: Workbook for Staging of Cancer, 2nd ed., pages 110-111
N2
Ipsilateral mediastinal
Mediastinal
lymph node stations
Slide28Lymph Nodes – N3; Distant Mets – M1a
N3
N3
M1a
Lymph Nodes
N3 Bilateral or contralateral
mediastinal,
scalene, supraclavicular
Distant Mets
M1a Distant lymph nodes including cervical nodes
Image source: AJCC Cancer Staging Atlas, Springer-Verlag, 2006.
Slide29M1 Lung Cancer
M1a Separate
tumor nodules in contralateral lobe Pleural nodules Malignant pleural or pericardial effusionM1b Distant metastasis
Pleural effusion
Pleura
Pleural space
Pleural effusion
(malignant or NOS)
Contralateral
tumor nodule
Slide30Pleural Effusion
TNM Guideline
Assume to be malignant (M1a) UNLESS
* Negative cytology on multiple exams AND
* Non-bloody, not an exudate AND
* Clinical judgement correlates with
benign diagnosis
Slide31Clinical Staging Criteria: Lung
Limited to evidence acquired
before treatment
Physical examination
Imaging studies
Laboratory tests
Staging procedures
AJCC Cancer Staging Manual 7
th
Edition, page 255
Slide32Clinical Staging Criteria: Lung
Imaging studies
computed and positron emission tomography)
Staging procedures
Bronchoscopy or esophagoscopy with ultrasound directed biopsies (EBUS, EUS)
Mediastinoscopy
Mediastinotomy
Thoracentesis
Thoracoscopy (VATS)
Exploratory thoracotomy
AJCC Cancer Staging Manual 7
th
Edition, page 255
Slide33Pathologic Staging Criteria: LungAJCC Cancer Staging Manual 7th Edition, page 256
All evidence acquired before treatment AND
Supplemented or modified by the
additional evidence acquired during and after surgery, particularly from pathologic examination
.
Slide34Pathologic Stage
Provides precise data used for estimating prognosis and calculating end results
pT requires
Resection of the primary tumor sufficient to evaluate the highest pT category OR
Biopsy that proves highest pT category
Slide35Pathologic Stage Cont’d
When T is evaluated clinically, N must be cN
Unresectable lung tumor with positive biopsy of contralateral scalene LN = cN p 4 AJCC 7 ED*
Do not record post-treatment stage
pN ideally entails removal of a sufficient number of lymph nodes to evaluate the highest pN category
If pathologic assessment of lymph nodes reveals negative nodes but the number of lymph node stations examined are fewer than suggested above, classify the N category as pN0
Slide36Stage Groups
Occult TX N0 M0
0 Tis N0 M0
IA T1a-b N0 M0
IB T2a N0 M0
IIA T1a-b, T2a N1 M0
T2b N0 M0
IIB T2b N1 M0
T3 N0 M0
IIIA T1-2 N2 M0
T3 N1-2 M0
T4 N0-1 M0
IIIB Any T N3 M0
T4 N2-3 M0
IV Any T Any N M1a-b
Slide37SSF 1 – Separate Tumor Nodules/ Ipsilateral Lung
Required by COC, SEER, NPCR
Location of separate tumor nodules affects T
Codes
000 No separate nodules noted
010 Separate nodules in ipsilat lung, same lobe
020 Separate nodules in ipsilat lung, different lobe
030 Separate nodules, ipsilat lung, same and
different lobe
040 Separate nodules, ipsilat lung, unknown
if same or different lobe
988 Not applicable: Information not collected
999 Unknown if separate tumor nodules; Not
documented in patient record
Slide38SSF 2 – Visceral Pleural Invasion/ Elastic Layer
Required by COC, SEERFor tumor < 3 cm (T1), invasion of visceral pleura upstages T PL1-PL2 T2PL3 T3
Source: virtualmedicalcentre.com/uploads/VMC/ DiseaseImages/598_Normal_L_Pleura.jpg
Surface of
visceral
pleura (PL 2) Pleural space
Visceral pleura (PL 1) beyond elastic layer
Lung
Parietal pleura
(PL 3)
Slide39Visceral Pleural Invasion
PL0—Within subpleural lung parenchyma or invading superficially into pleural connective tissue beneath elastic layer.
Not a T descriptor; T category should be assigned on other features. PL1—Invades beyond elastic layer PL2—Invades to pleural surfacePL1/PL2 indicate VPI; T2 descriptor PL3—Tumor invades into any part of parietal pleuraT3 descriptor
Reprinted from Journal of Thoracic Oncology.
Copyright © 2008 Aletta Ann Frazier, MD.
Slide40SSF 2 – Visceral Pleural Invasion/ Elastic Layer
Required by COC, SEER
Codes
000 No evidence of visceral pleural invasion; not
through elastic layer (PL 0)
010 Beyond visceral elastic pleura, limited to
pulmonary pleura; through elastic layer (PL 1)
020 To surface of pulmonary pleura; Extends to
surface of visceral pleura (PL 2)
030 Extends to parietal pleura (PL 3)
040 Invasion of pleura, NOS
988 Not applicable: Information not collected
998 No histology of pleura
999 Unknown if visceral pleural invasion is
present; Not documented in patient record
Slide41Coding TNM Factoids
Slide42cTNM – Blanks, X, or Number
Meets c classification criteria
Use x or numbers
M must be 0 or 1
Does not meet c classification criteria
T, N, and M all blank
Group stage 99
Example: incidental/surprise diagnosis
Chest x-ray your facility; no further information
Slide43pTNM – Blanks, X, or Number
Meets p classification criteria
T and N either X or numbers
M0 or M1
Does not meet p classification criteria
T, N, and M blank
Group stage 99
Example: No resection of primary
Slide44Source of Information?
Louanne Currance
Louanne spoke with Donna Gress to clarify when T, N, or M should be blank
Slide45T4 Cont’d
Is it possible to code pT without gross tumor removal?
What do you think?
Example (verbal)
Slide46Guess What – Information in Text
T2 invasion hilar fat (unless higher by size)
T2a
Invasion across fissure
Direct invasion adjacent lobe (unless higher by size)
Slide47T3
Invasion mediastinal pleura (no matter what tumor size)
Pericardial invasion
Note T3 does not include malignant pericardial infusion
Invasion of sternum
Phrenic nerve invasion
Slide48T4
Vocal
cord
paralysis can be:
Invasion of vocal cords T4 OR
LN involvement N2 (find out why)
Pancoast tumor
Involvement of brachial plexus
Invasion vertebra or spinal canal
Direct extension to mediastinal fat
Slide49Must Know
Direct extension to LN coded as LN metastases
Example: 2.8 cm tumor confined to lung with invasion of intrapulmonary node – code
T1
N1
T based on size of tumor – N based on invasion of node
Slide50Requirements for pN
First “drainage” station depends on lobe
Is one node enough for pN?
Cannot use molecular markers such as EGFR and K-
ras
Only sentinel node – specific circumstances
Lymphoma with one clinically positive node
Most chapters require 4 nodes
Lung – no evidence-based studies to confirm number of nodes
Slide51How Many LN for pN
Still investigational p 255 AJCC 7 ED
Evidence to support
6 or more hilar AND mediastinal nodes
At least 3 nodes from N1 category
At least 3 mediastinal nodes (includes sub-carinal nodes)
Slide52Lymph Node Stations – N Value
N2
Ipsilateral surgical stations 1-9
Rt
lung: Stations 2, 4, 7, 10, and 11
Lt lung: Stations 5, 6, 7, 10, and 11
LL tumors should include Station 9
N3
Ipsilateral surgical stations 10-14
Stations 12-14 lobectomy or pneumonectomy
Slide53M1a
Discontinuous tumor foci parietal pleura
Ipsilateral
NOT direct extension
Discontinuous tumor foci visceral pleura
Ipsilateral
NOT direct extension
Malignant pericardial effusion
Discontinuous tumor nodules pericardium
Slide54M1b
Discontinuous tumors chest wall
Not direct extension
Discontinuous tumors diaphragm
Not direct extension
Slide55Questions?